Medenos is an early-stage biopharmaceutical company with the mission to understand the fundamental mechanisms of bone biology and to produce disease-modifying therapeutics for both common and rare painful musculoskeletal diseases.

Our discoveries include the pathogenesis of these diseases and novel small and large molecules to address their underlying causes. Our portfolio of research and intellectual property originates from the Johns Hopkins Center for Musculoskeletal Research.

Bone Has a Sixth Sense

The Skeletal Interoceptive Circuit